CYAD(Delisted)
Celyad OncologyยทNASDAQ
--
--(--)
CYAD Profile
Celyad Oncology Sa
A biotechnology company focused on chimeric antigen receptor T cell therapies for cancer
Axis Business Park Rue Andre Dumont 9, BE-1435 Mont-Saint-Guibert, Belgium
--
Celyad Oncology SA is a biotechnology company focused on discovering and developing innovative technologies for chimeric antigen receptor (CAR) T cell therapies. The company is focused on leveraging the true potential of its proprietary technology platform and intellectual property and supporting the development of next-generation CAR T drug candidates for solid tumors and hematological malignancies.
